Summary

Executive Summary

According to a research report published by Azoth Analytics in November 2022, the Global Biosimulation Market was valued at USD 3011.50 Million in the year 2021. Biosimulation helps to increase the probability of success in human clinical trials, the most expensive part of drug development. Biosimulation helps to optimize dosing for different populations for enhanced safety and efficacy. New drugs can cause significant increases in retail spending because they are more expensive, in high demand, or both. Currently, In-Silico methods are outpacing various stages of drug discovery, particularly in biomedicine sciences.

Biosimulation drug discovery offers numerous opportunities for error elimination through computer simulation, which can improve drug performance and accuracy. In the forthcoming years, there will be more potential for the Biosimulation market to flourish due to the expanding applications and rising use of personalized medicine and biosimulation solutions for the development of paediatric drugs. Companies around the world use key strategies such as Component launches, business expansions, mergers and acquisitions, patents and approvals, agreements and collaborations.

The key software methods for developing a drug are structure-based drug design, molecular modelling, structure-based virtual screening, ligand interaction, and molecular dynamics. New technologies such as virtual reality and artificial intelligence (AI) are expanding the opportunities for drug discovery. Americas has the lucrative growth in the Biosimulation industry and the United States remains the country with the earliest launches accounting for 72 NASs launched in 2021.



Scope of the Report

• The report presents the analysis of the Biosimulation market for the historical period of 2018-2021, the estimated year 2022 and the forecast period of 2023-2028.

• The report analyses the Biosimulation Market by Value (USD Million).

• The report analyses the Biosimulation Market by Component (Software, Service)

• The report analyses the Biosimulation Market by Application (Drug Discovery, Pre-Clinical, Clinical)

• The report analyses the Biosimulation Market by End-User (Academic & Government Research Institutes, Pharmaceutical & Biotech Companies, Contract Research Organization, Regulatory Authorities)

• The Global Biosimulation Market has been analysed by countries (United States, Canada, Mexico, Germany, United Kingdom, France, Italy, China, Japan, India)

• The attractiveness of the market has been presented by region, by Component, Application and End-User.

• Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.

• The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include – Certara, Inc., Simulations Plus, Inc., Schrödinger, Inc., Dassault Systèmes, Physiomics plc, Thermo Fisher Scientific, Instem plc, Advanced Chemistry Development, Inc., Chemical Computing Group, Optibrium



Key Target Audience

• Pharmaceutical and Healthcare Companies

• Pharmaceutical Research and Development Companies

• Consulting and Advisory Firms

• Government and Policy Makers

• Regulatory Authorities

ページTOPに戻る

Table of Contents

1. Introduction

1.1 Biosimulation Overview

1.2 Scope of Research

2. Executive Summary

2.1 Market Dashboard

2.2 Regional Insights

2.3 Market Ecosystem Factors

3. Research Methodology

3.1 Data Collection Process

3.2 Market Trajectory Estimation

3.3 Market Size Calculation

4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Trends

4.5 Impact assessment of Market Dynamics

5. Value Chain Analysis

5.1 Research and Development

5.2 Leading Developers and Providers

5.3 Top Ten Pharma Companies

5.4 End Use Industry

6. Covid-19 Impact Assessment

6.1 Assessment of Degree of Impact of Covid-19 on the Biosimulation Market

6.2 Region-Wise Quarterly Covid Impact Analysis

7. Porter's Five Forces Analysis

8. Macro Economic Indicator Outlook

8.1 Pharmaceutical Industry Growth

8.2 Global Healthcare Expenditure

8.3 Global Biopharma R&D Spending

8.4 Medicines in Development

8.5 Global Software Industry

9. Average Selling Price Analysis

9.1 Average Selling Price, By Region

9.2 Average Selling Price, By Component

10. Competitive Positioning

10.1 Companies Component Positioning

10.2 Market Position Matrix

10.3 Market Share Analysis

10.3.1 Certara, Inc.

10.3.2 Simulations Plus, Inc.

10.3.3 Schrˆdinger, Inc.

10.3.4 Dassault SystËmes

10.3.5 Physiomics plc

10.3.6 Thermo Fisher Scientific

10.3.7 Instem plc

10.3.8 Advanced Chemistry Development, Inc.

10.3.9 Chemical Computing Group

10.3.10 Optibrium

11. Global Biosimulation Market Trends and Forecast Analysis, 2018-2028, USD Million & CAGR

11.1 Macro Economic Factor Impact Index

11.2 Global Biosimulation Market: Dashboard

11.3 Global Biosimulation Market Size, By Value, 2018-2021 (USD Million)

11.4 Global Biosimulation Market Size, By Value, 2022-2028 (USD Million)

11.5 Global Biosimulation Market: Summary

12. Global Biosimulation Market Trend And Forecast Analysis, 2018-2028, By Component

12.1 Global Biosimulation Market Trend And Forecast Analysis, By Component: Snapshot

12.2 Software

12.3 Service

13. Global Biosimulation Market Trend And Forecast Analysis, 2018-2028, By Application

13.1 Global Biosimulation Market Trend And Forecast Analysis, By Application: Snapshot

13.2 Drug Discovery

13.3 Pre-Clinical

13.4 Clinical

14. Global Biosimulation Market Trend And Forecast Analysis, 2018-2028, By End-User

14.1 Global Biosimulation Market Trend And Forecast Analysis, By End-User: Snapshot

14.2 Academic & Government Research Institutes

14.3 Pharmaceutical & Biotech Companies

14.4 Contract Research Organization

14.5 Regulatory Authorities

15. Global Biosimulation Market Trend And Forecast Analysis, 2018-2028, By Region

15.1 Regional Coverage of the Study

16. Americas Biosimulation Market Trends and Forecast Analysis, 2018-2028, USD Million & CAGR

16.1 Macro Economic Factor Impact Index

16.2 Impact analysis of market dynamics on Biosimulation Market

16.3 Americas Biosimulation Market: Dashboard

16.4 Americas Biosimulation Market Size, By Value, 2018-2021(USD Million)

16.5 Americas Biosimulation Market Size, By Value, 2022-2028 (USD Million)

16.6 Americas Biosimulation Market Trend And Forecast Analysis: Segmentation

16.6.1 By Component

16.6.2 By Application

16.6.3 By End-User

16.6.4 By Country

16.6.4.1 United States

16.6.4.2 Canada

16.6.4.3 Mexico

16.6.4.4 Rest of Americas

17. Europe Biosimulation Market Trends and Forecast Analysis, 2018-2028, USD Million & CAGR

17.1 Macro Economic Factor Impact Index

17.2 Impact analysis of market dynamics on Biosimulation Market

17.3 Europe Biosimulation Market: Dashboard

17.4 Europe Biosimulation Market Size, By Value, 2018-2021(USD Million)

17.5 Europe Biosimulation Market Size, By Value, 2022-2028 (USD Million)

17.6 Europe Biosimulation Market Trend And Forecast Analysis: Segmentation

17.6.1 By Component

17.6.2 By Application

17.6.3 By End-User

17.6.4 By Country

17.6.4.1 Germany

17.6.4.2 United Kingdom

17.6.4.3 France

17.6.4.4 Italy

17.6.4.5 Rest of Europe

18. Asia Pacific Biosimulation Market Trends and Forecast Analysis, 2018-2028, USD Million & CAGR

18.1 Macro Economic Factor Impact Index

18.2 Impact analysis of market dynamics on Biosimulation Market

18.3 Asia Pacific Biosimulation Market: Dashboard

18.4 Asia Pacific Biosimulation Market Size, By Value, 2018-2021(USD Million)

18.5 Asia Pacific Biosimulation Market Size, By Value, 2022-2028 (USD Million)

18.6 Asia Pacific Biosimulation Market Trend And Forecast Analysis: Segmentation

18.6.1 By Component

18.6.2 By Application

18.6.3 By End-User

18.6.4 By Country

18.6.4.1 China

18.6.4.2 Japan

18.6.4.3 India

18.6.4.4 Rest of APAC

19. Middle East & Africa Biosimulation Market Trends and Forecast Analysis, 2018-2028, USD Million & CAGR

19.1 Impact analysis of market dynamics on Biosimulation Market

19.2 Middle East & Africa Biosimulation Market: Snapshot

19.3 Middle East & Africa Biosimulation Market Size, By Value, 2018-2021(USD Million)

19.4 Middle East & Africa Biosimulation Market Size, By Value, 2022-2028 (USD Million)

19.6 Middle East & Africa Biosimulation Market Trend And Forecast Analysis: Segmentation

19.6.1 By Component

19.6.2 By Application

19.6.3 By End-User